What medtech CEOs are saying this week about Trump’s potential tariffs
During quarterly earnings calls across the medtech industry, a recurring question has been on investors’ minds: If President-elect Donald Trump implements his plans for blanket 10% to 20% | During quarterly earnings calls this week across the medtech industry, a recurring question has been on investors’ minds.